Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of clinical phenotypes in schizophrenia: the role of lurasidone
Marco Andrea Riva, Umberto Albert, Sergio De Filippis, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 13

Showing 13 citing articles:

Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy
Itaru Miura, Sho Horikoshi, Mizue Ichinose, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 3023-3031
Open Access | Times Cited: 13
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation
Clara Cavallotto, Stefania Chiappini, Alessio Mosca, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2206-2206
Open Access | Times Cited: 5
Novel missense variants in brain morphogenic genes associated with depression and schizophrenia
Maxim Karagyaur, A. L. Primak, Kirill Bozov, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
The role of lumateperone in the treatment of schizophrenia
Alveena Batool Syed, James Robert Brašić
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 28
Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence
F. Mora, Carlos Gómez Sánchez-Lafuente, Mariano de Iceta Ibáñez de Gauna, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
The safety analysis of Lurasidone based on the real-world data of FAERS database
Ziyi Luo, Mengting Zhang, Weijian Liang, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Towards full recovery with lurasidone: effective doses in the treatment of agitation, affective, positive and cognitive symptoms in schizophrenia, and dual psychosis
María Teresa Carreras, Luis Jiménez Suárez, Laura Lago García, et al.
Drugs in Context (2024) Vol. 13, pp. 1-18
Open Access | Times Cited: 3
Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice
Andrea Fiorillo, Alessandro Cuomo, Gaia Sampogna, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 16, pp. 1801-1818
Open Access | Times Cited: 10
Lurasidone for the treatment of schizophrenia in adult and paediatric populations
Teresa Guilera, Juan Pablo Chart-Pascual, Maria del Carmen Blasco, et al.
Drugs in Context (2023) Vol. 12, pp. 1-17
Open Access | Times Cited: 5
Adherence to Typical Antipsychotics among Patients with Schizophrenia in Uganda: A Cross-Sectional Study
Moses Kule, Mark Mohan Kaggwa
Schizophrenia Research and Treatment (2023) Vol. 2023, pp. 1-12
Open Access | Times Cited: 4
Aminothiolation of 2-(2-bromophenyl)quinazolinones with elemental sulfur to access 7H-benzo[4,5]isothiazolo[3,2-b]quinazolinones through C–S/S–N bond formation under metal-free condition
Qiong Wu, Zhihong Deng, Dayu Xie, et al.
Tetrahedron (2022) Vol. 124, pp. 132911-132911
Closed Access | Times Cited: 3
Lurasidone-related adverse events: A comprehensive analysis from the FAERs database in real-world settings
Jinlong Zhu, Lu Hou, Qin Zhou, et al.
European Neuropsychopharmacology (2024) Vol. 90, pp. 60-61
Closed Access
Therapeutic Appropriateness of Cariprazine in the Management of Schizophrenia: Experts’ Opinion using a Delphi Approach
Bernardo Dell’Osso, Antonello Bellomo, Andreas Conca, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 11, pp. 2206-2216
Closed Access | Times Cited: 1
Clinical Effectiveness of Lurasidone Monotherapy in Patients with Acute Episodes of Schizophrenia and Associated Symptoms of Depression
A M Reznik, Timur Syunyakov, Inessa Yu. Akhmerova, et al.
Consortium Psychiatricum (2022) Vol. 3, Iss. 3, pp. 58-72
Open Access
Page 1

Scroll to top